https://www.globenewswire.com/news-release/2026/04/16/3275735/0/en/AB-Science-provides-an-update-on-its-clinical-development-program.html
AB Science provides an update on its clinical development
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM AB SCIENCE SECURES EUR 25 MILLION CLINICAL TRIAL INSURANCE FOR ITS PHASE III TRIAL...
ab sciencean updateprovidesclinicaldevelopment
https://www.globenewswire.com/news-release/2026/04/20/3277390/0/en/AB-Science-New-publication-on-medrxiv-demonstrating-substantial-survival-benefits-and-preserved-quality-of-life-with-masitinib-in-ALS-patients.html
AB Science: New publication on medrxiv demonstrating
PRESS RELEASE AB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV DEMONSTRATING SUBSTANTIAL SURVIVAL BENEFITS AND PRESERVED QUALITY OF LIFE WITH MASITINIB IN...
ab sciencenew publicationmedrxivdemonstrating
https://www.globenewswire.com/fr/news-release/2025/10/16/3168256/0/en/ab-science-provides-intitial-phase-1-data-for-the-combination-of-ab8939-with-venetoclax-for-the-treatment-of-refractory-or-relapsed-acute-myeloid-leukemia.html
AB Science provides intitial Phase 1 data for the
PRESS RELEASE AB SCIENCE PROVIDES INITIAL PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE...
ab scienceprovidesphasedata
https://www.benzinga.com/quote/ABSCF/guidance
AB SCIENCE PARIS ORD by AB Science, Paris Stock Guidance | OTC:ABSCF | Benzinga
Access expert guidance on AB SCIENCE PARIS ORD by AB Science, Paris stock with Benzinga. Stay informed on market forecasts, trends, and investment strategies...
ab scienceby stockparisordguidance
https://www.polisci.washington.edu/courses/2024/autumn/pol%20s/201/ab
POL S 201 AB Autumn 2024 | Department of Political Science | University of Washington